We are live on ! Find out more
CC

Colrain Capital Portfolio holdings

AUM $259M
1-Year Est. Return 63.6%
This Fund
S&P 500
This Quarter Est. Return
+7.62%
1 Year Est. Return
+63.6%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$55.6M
AUM Growth
-$41.5M
Cap. Flow
-$56.9M
Cap. Flow %
-102.44%
Top 10 Hldgs %
63.04%
Holding
32
New
1
Increased
2
Reduced
20
Closed
9

Top Buys

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$1.74M
2
VST icon
Vistra
VST
+$1.11M
3
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$545K

Top Sells

Rank Stock Value
1
MOS icon
The Mosaic Company
MOS
+$8.34M
2
HES
Hess
HES
+$5.19M
3
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$5.06M
4
CI icon
Cigna
CI
+$4.46M
5
AAPL icon
Apple
AAPL
+$4.31M

Sector Composition

Rank Sector Weight
1 Healthcare 21.87%
2 Technology 14.45%
3 Materials 11.42%
4 Communication Services 10.32%
5 Consumer Staples 9.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MOS icon
1
The Mosaic Company
MOS
$6.98B
$5.21M 9.37%
163,292
-245,915
-60% -$8.34M
HES
2
DELISTED
Hess
HES
$4.34M 7.82%
49,750
-64,310
-56% -$5.19M
VST icon
3
Vistra
VST
$54.7B
$3.92M 7.06%
211,500
+64,250
+44% +$1.11M
CVS icon
4
CVS Health
CVS
$141B
$3.75M 6.75%
45,000
-47,885
-52% -$3.92M
GOOGL icon
5
Alphabet (Google) Class A
GOOGL
$4.24T
$3.6M 6.48%
29,500
-43,300
-59% -$5.06M
IP icon
6
International Paper
IP
$19.2B
$2.97M 5.35%
51,216
-65,919
-56% -$3.76M
AAPL icon
7
Apple
AAPL
$4.81T
$2.94M 5.3%
21,500
-33,260
-61% -$4.31M
WMT icon
8
Walmart Inc
WMT
$878B
$2.82M 5.07%
6,000
-7,500
-56% -$349K
MSFT icon
9
Microsoft
MSFT
$2.95T
$2.8M 5.04%
10,345
-13,054
-56% -$3.32M
CI icon
10
Cigna
CI
$76.8B
$2.67M 4.8%
11,250
-17,850
-61% -$4.46M
ABBV icon
11
AbbVie
ABBV
$452B
$2.43M 4.37%
21,550
-19,712
-48% -$2.22M
LHX icon
12
L3Harris
LHX
$51.7B
$2.3M 4.13%
10,625
-9,285
-47% -$2M
QCOM icon
13
Qualcomm
QCOM
$183B
$2.29M 4.11%
16,000
-20,815
-57% -$2.81M
BG icon
14
Bunge Global
BG
$23.6B
$2.23M 4.01%
28,500
-35,800
-56% -$3.02M
CMCSA icon
15
Comcast
CMCSA
$85.1B
$2.14M 3.85%
37,500
-54,000
-59% -$3.02M
C icon
16
Citigroup
C
$223B
$2.09M 3.76%
29,575
-34,300
-54% -$2.54M
VRTX icon
17
Vertex Pharmaceuticals
VRTX
$122B
$1.67M 3.01%
+8,300
New +$1.74M
MDT icon
18
Medtronic
MDT
$105B
$1.44M 2.58%
11,500
-15,700
-58% -$1.97M
BRK.B icon
19
Berkshire Hathaway Class B
BRK.B
$1.06T
$1.43M 2.57%
5,150
+1,950
+61% +$545K
NEM icon
20
Newmont
NEM
$98.7B
$1.14M 2.05%
18,000
-2,436
-12% -$163K
GDX icon
21
VanEck Gold Miners ETF
GDX
$22.7B
$968K 1.74%
28,500
-40,695
-59% -$1.49M
JPM icon
22
JPMorgan Chase
JPM
$918B
$233K 0.42%
1,500
-1,600
-52% -$251K
UNH icon
23
UnitedHealth
UNH
$396B
$200K 0.36%
500
-1,250
-71% -$498K
CTVA icon
24
Corteva
CTVA
$58.1B
– –
-6,550
Closed -$254K
DAL icon
25
Delta Air Lines
DAL
$55.7B
– –
-5,400
Closed -$217K
1
2

Similar funds

NAM
NewGen Asset Management Toronto, Ontario, Canada $259M AUM 140.76% 1-Year Est. Return
CCAM
Codex Capital Asset Management Dallas, Texas $259M AUM 32.71% 1-Year Est. Return
QP
Quartz Partners Saratoga Springs, New York $259M AUM 26.69% 1-Year Est. Return
BFA
Bluestem Financial Advisors Champaign, Illinois $259M AUM 12.01% 1-Year Est. Return
PW
Potentia Wealth San Jose, California $259M AUM 19.98% 1-Year Est. Return
BFP
Beacon Financial Planning Hyannis, Massachusetts $258M AUM 16.1% 1-Year Est. Return
TC
Toews Corporation Northfield, New Jersey $259M AUM 5.15% 1-Year Est. Return
FC
Financial Council Towson, Maryland $259M AUM 21.02% 1-Year Est. Return

Colrain Capital's Q2 2021 Portfolio in Review

As of Q2 2021, Colrain Capital held 32 positions worth $55.6M, down 43% from $97M the previous quarter. Its ten largest holdings account for 63% of the portfolio.

Colrain Capital withdrew a net $56.9M in Q2 2021, closing 9 positions and reducing 20 holdings. Its most notable exit was Pfizer, an estimated $574K position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 22% of assets, down from 23% a quarter earlier, followed by Technology and Materials.

Against the trend, Colrain Capital opened a new position in Vertex Pharmaceuticals worth $1.67M.

  • Colrain Capital's largest Q2 2021 buy was Vertex Pharmaceuticals: 8,300 shares worth $1.67M.
  • Colrain Capital added most to Vistra in Q2 2021, an estimated $1.11M increase.
  • Colrain Capital's biggest Q2 2021 reduction was The Mosaic Company, cutting an estimated $8.34M.
  • Colrain Capital fully exited Pfizer in Q2 2021, selling an estimated $574K.
  • Colrain Capital's ten largest holdings make up 63% of its $55.6M portfolio in Q2 2021.
  • Colrain Capital opened 1 new position and closed 9 in Q2 2021.
  • Colrain Capital's portfolio value fell 43% quarter-over-quarter to $55.6M.

Based on Colrain Capital's 13F filing for Q2 2021, filed 13 Aug 2021.